Ewing's Sarcoma News and Research

RSS
The Ewing's family of tumors (EFT) includes primary tumors of bone (classic Ewing's sarcoma, primitive neuroectodermal tumor, and Askin tumor) and extraosseous primary tumors {National Cancer Institute}.
The Max Cure Foundation, SWCRF partner to fund pediatric cancer research

The Max Cure Foundation, SWCRF partner to fund pediatric cancer research

Six new scientists to receive SWCRF grants for cancer research

Six new scientists to receive SWCRF grants for cancer research

Nine young clinical investigators earn recognition from Damon Runyon Cancer Research Foundation

Nine young clinical investigators earn recognition from Damon Runyon Cancer Research Foundation

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

CITN selects Cytheris' CYT107 for initial clinical trials at network institutions

CITN selects Cytheris' CYT107 for initial clinical trials at network institutions

Reprogrammed herpes virus can improve early cancer diagnosis

Reprogrammed herpes virus can improve early cancer diagnosis

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Research on rare cancers

Research on rare cancers

Arsenic agent for leukemia beneficial in treating medulloblastoma, Ewing's Sarcoma

Arsenic agent for leukemia beneficial in treating medulloblastoma, Ewing's Sarcoma

Research: Arsenic trioxide may benefit individuals with connective brain tumors

Research: Arsenic trioxide may benefit individuals with connective brain tumors

Interim results from Cytheris CYT107 Phase I clinical trial in TCD bone marrow transplant patients

Interim results from Cytheris CYT107 Phase I clinical trial in TCD bone marrow transplant patients

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

HSV1716 clinical trial for childhood cancer receives FDA grant

HSV1716 clinical trial for childhood cancer receives FDA grant

Cincinnati Children's Hospital Medical Center named Centers of Excellence for Molecular Hematology

Cincinnati Children's Hospital Medical Center named Centers of Excellence for Molecular Hematology

Researchers develop new RNA molecule approach to kill cancer cells

Researchers develop new RNA molecule approach to kill cancer cells

TGen researchers use RNAi-based screening to study Ewing's sarcoma

TGen researchers use RNAi-based screening to study Ewing's sarcoma

U.S. clinical trials provide further evidence of importance of storing umbilical cord blood

U.S. clinical trials provide further evidence of importance of storing umbilical cord blood

Bedford Laboratories launches Dactinomycin for Injection

Bedford Laboratories launches Dactinomycin for Injection

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug